PROSTIN VR

This brand name is authorized in Canada, Estonia, Hong Kong, Croatia, Israel, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, United Kingdom, United States, South Africa

Active ingredients

The drug PROSTIN VR contains one active pharmaceutical ingredient (API):

1 Alprostadil UNII F5TD010360 - ALPROSTADIL

Alprostadil is chemically identical to prostaglandin E1, the actions of which include vasodilatation of blood vessels in the erectile tissues of the corpora cavernosa and increase in cavernosal artery blood flow, causing penile rigidity. Read about Alprostadil

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PROSTIN VR Concentrate for solution for infusion	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C01EA01	Alprostadil	C Cardiovascular system → C01 Cardiac therapy → C01E Other cardiac preparations → C01EA Prostaglandins
Discover more medicines within C01EA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00559253
Country: EE	Ravimiamet	Identifier(s): 1692299, 1758382, 1759091
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 47462
Country: HK	Department of Health Drug Office	Identifier(s): 22532
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-396564180
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8925
Country: MT	Medicines Authority	Identifier(s): AA565/55401, AA565/55403
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 70165
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 3473
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100056144
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67256001
Country: SG	Health Sciences Authority	Identifier(s): 02280P
Country: US	FDA, National Drug Code	Identifier(s): 0009-3169
Country: ZA	Health Products Regulatory Authority	Identifier(s): Q/7.1/32